🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A descriptive study that will quantify the mean IgG antibodies remaining in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05476822
Treatments Being Tested
The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldw...
Status
Recruiting
Location
Johns Hopkins Hospital
Start Date
2020-04-13
Trial ID
NCT05197621
Treatments Being Tested
To evaluate immune responses of an Investigational mRNA-1273.815 vaccine ag...
Status
Completed
Location
Paratus Canberra
Start Date
2024-04-08
Trial ID
NCT06354998
Treatments Being Tested
This is an observational cohort study to evaluate real-world vaccine effect...
Status
Completed
Location
Kaiser Permanente Southern California
Start Date
2020-12-18
Trial ID
NCT05933304
The goals of this study are to assess initial or booster vaccine performanc...
Status
Terminated
Location
IU Health Joe and Shelly Schwarz Cancer Center
Start Date
2021-06-30
Trial ID
NCT04930055
Treatments Being Tested
This study is a 12-month, four-arm parallel-group randomized control trial ...
Status
Terminated
Location
Scarborough Health Network
Start Date
2021-09-30
Trial ID
NCT05022329
Treatments Being Tested
Investigators will evaluate the immunogenicity of a third dose of mRNA-1273...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2021-09-10
Trial ID
NCT05054218
Treatments Being Tested
The main goal of this study is to evaluate the outcomes of pregnancy in fem...
Status
Terminated
Location
IQVIA Call Center for United States and Canada
Start Date
2021-09-01
Trial ID
NCT04958304
Investigators are conducting a study on alternative treatments for patients...
Status
Recruiting
Location
NIH Clinical Center
Start Date
2024-03-01
Trial ID
NCT06441955
This is a 2-part study to evaluate the immunogenicity, safety, and reactoge...
Status
Completed
Location
Aberdeen Royal Infirmary - PPDS
Start Date
2022-02-16
Trial ID
NCT05249829
Treatments Being Tested